Oral vinorelbine for the treatment of metastatic non-small cell lung cancer in elderly patients: a phase II trial of efficacy and toxicity
- 1 March 2004
- journal article
- clinical trial
- Published by Elsevier
- Vol. 43 (3) , 345-353
- https://doi.org/10.1016/j.lungcan.2003.09.012
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) Phase III Randomized TrialJNCI Journal of the National Cancer Institute, 2003
- The COMpliance PraxiS Survey (COMPASS): a multidimensional instrument to monitor compliance for patients on antihypertensive medicationJournal of Human Hypertension, 2002
- Elderly patients with lung cancer: Biases and evidenceCurrent Treatment Options in Oncology, 2002
- A multicenter randomized phase II study of oral vs. intravenous vinorelbine in advanced non-small-cell lung cancer patientsAnnals of Oncology, 2001
- Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1999
- Patient preferences for oral versus intravenous palliative chemotherapy.Journal of Clinical Oncology, 1997
- Treatment tolerance of elderly cancer patients entered onto phase II clinical trials: an Illinois Cancer Center study.Journal of Clinical Oncology, 1994
- Primary non-compliance with prescribed medication in primary care.BMJ, 1993
- Clinical trials and drug toxicity in the elderly. The experience of the eastern cooperative oncology groupCancer, 1983
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958